(NASDAQ:JYD),(NASDAQ:SFM),(NYSE:ARE),(NYSE:STUB), LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged […]

DEADLINE ALERT for JYD, STUB, ARE, and SFM: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire December 30, 2025 LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of

(NYSE:FUN),(NYSE:INSP),(NASDAQ:TLX), LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged

DEADLINE ALERT for FUN, INSP, and TLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire December 30, 2025 LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders

Tiger BioSciences highlights a series of major clinical and scientific achievements resulting from the company's expanded investment in evidence‑based research throughout 2025. This strategic focus has strengthened Tiger BioSciences' position as a market leader heading into 2026, with a portfolio increasingly defined by data, clinical validation, and scientific evidence. https://mma.prnewswire.com/media/2823019/TigerBiosciencesCircleColor_copy_Logo.jpg In 2025, Tiger BioSciences supported

(NASDAQ:CETX),(Pinksheets:CETXP),(PinkSheets:CETXP),(NASDAQ:CETXW), Hauppauge, NY, Dec. 30, 2025 (GLOBE NEWSWIRE) — Cemtrex, Inc. (NASDAQ: CETX) (the “Company”), an advanced security technology and industrial services company, today announced that it has entered into a definitive agreement for the purchase of approximately 888,889 shares and / or pre funded warrants with a single institutional investor, at a purchase price

Miami, FL / Porto, Portugal , Dec. 30, 2025 (GLOBE NEWSWIRE) — Naoris Protocol, the world's first decentralized cybersecurity mesh powered by a post-quantum blockchain and distributed AI, is gearing up for its highly anticipated Mainnet launch, following a banner year of growth in 2025. 2025 marked a decisive shift in how governments, enterprises, and

New York, NY, Dec. 30, 2025 (GLOBE NEWSWIRE) — Divexa Exchange has released its Annual Compliance and Risk Governance Whitepaper, providing a comprehensive overview of the platform's governance structure, risk-management architecture, and regulatory alignment efforts across global jurisdictions. The publication reflects Divexa Exchange's ongoing commitment to transparency, operational discipline, and institution-ready standards in the evolving

(NYSE:INSP), LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock

(NYSE:FCX), LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15,